Rodrigues M R, Sá Miranda M C, Amaral O
Instituto de Genética Medica Jacinto de Magalhaes, Unidade de Enzimologia, Porto, Portugal.
Blood Cells Mol Dis. 2004 Nov-Dec;33(3):362-4. doi: 10.1016/j.bcmd.2004.07.005.
Chitotriosidase is a human chitinase produced by macrophages. Its enzymatic activity is markedly elevated in serum of patients suffering from lysosomal storage disorders, as well as other diseases in which macrophages are activated. Therefore, it is a useful tool as a secondary marker in the diagnosis of several disorders including Gaucher disease type 1 and Niemann-Pick disease. The determination of chitotriosidase levels as a diagnosis complement in some lysosomal storage disorders and in enzyme replacement therapy follow-up of Gaucher disease patients is of great importance. However, the fact that a mutation caused by a 24-bp duplication in the CHIT1 gene resulting in deficiency of plasma chitotriosidase activity is very frequent makes the establishment of the frequency of this mutation in different population groups necessary. Furthermore, in order to validate the use of chitotriosidase activity as a marker, it is indispensable to screen individuals for this particular mutation. In this work, we present the results of a study where the allelic frequency of the above mentioned CHIT1 gene mutation was determined in the Portuguese population by real-time PCR. The frequency of carriers encountered in this sample of Portuguese individuals was of 37%.
壳三糖苷酶是一种由巨噬细胞产生的人类几丁质酶。在患有溶酶体贮积症的患者以及巨噬细胞被激活的其他疾病患者的血清中,其酶活性会显著升高。因此,它是诊断包括1型戈谢病和尼曼-匹克病在内的多种疾病的有用辅助标志物。测定壳三糖苷酶水平作为某些溶酶体贮积症的诊断补充以及戈谢病患者酶替代治疗随访的指标具有重要意义。然而,CHIT1基因中一个24个碱基对重复导致血浆壳三糖苷酶活性缺乏的突变非常常见,这使得确定该突变在不同人群中的频率成为必要。此外,为了验证将壳三糖苷酶活性用作标志物的有效性,对个体进行这种特定突变的筛查是必不可少的。在这项工作中,我们展示了一项研究的结果,该研究通过实时PCR测定了葡萄牙人群中上述CHIT1基因突变的等位基因频率。在这个葡萄牙个体样本中遇到携带者的频率为37%。